June 16, 2026 a 09:00 pm
CME: Analysts Ratings - CME Group Inc.
CME Group Inc., a major global player in futures and options exchanges, demonstrates robust activity in diverse sectors like interest rates, equities, and commodities. Recent analyst ratings indicate a balanced outlook with a slight shift towards caution, hinting at underlying market complexities amidst global economic fluctuations. The company's established position offers resilience, yet the current sentiment data underscores a nuanced approach for potential investors.
Historical Stock Grades
As of June 2026, CME Group's analyst ratings reveal a detailed landscape of sentiment:
| Rating Category | Number of Ratings | Score Representation |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 4 | |
| Hold | 7 | |
| Sell | 1 | |
| Strong Sell | 2 |
Sentiment development
CME's analyst ratings over recent months show a moderate increase in caution. The trend indicates a rise in Hold ratings, suggesting analysts are taking a more reserved stance despite a stable economic environment.
- Total ratings have remained relatively stable with minor monthly fluctuations.
- Hold ratings have seen a consistent increase, reflecting a shift towards caution.
- Strong Buy ratings remain under pressure, indicating a cautious optimism among analysts.
Percentage trends
Analyzing percentage distributions, there is a noticeable shift towards Hold ratings, with a decrease in immediate Buy or Strong Buy recommendations. This emphasizes a heightened focus on cautious investment strategies.
- Strong Buy ratings dropped from 17% in early 2025 to 12.5% by mid-2026.
- Hold ratings now make up 43.75% of all recommendations, up from 41%.
- The trend shows increasing analyst caution amid market uncertainties.
Latest Analyst Recommendations
Recent recommendations reflect varying degrees of confidence and prudence in CME Group's performance. The data presents a balanced mix of upgrades and maintenance, indicating a stable outlook with selective opportunities.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-11 | Buy | Neutral | Rothschild & Co |
| 2026-04-23 | Equal Weight | Equal Weight | Barclays |
| 2026-04-23 | Overweight | Overweight | Morgan Stanley |
| 2026-04-15 | Overweight | Overweight | Piper Sandler |
| 2026-04-13 | Equal Weight | Equal Weight | Barclays |
Analyst Recommendations with Change of Opinion
Shifts in these recommendations underscore market dynamics and highlight possible adjustments in CME’s positioning. The recent upgrades suggest confidence in strategic adjustments, while downgrades reflect an adaptable yet cautious stance.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-11 | Buy | Neutral | Rothschild & Co |
| 2026-03-04 | Hold | Buy | Argus Research |
| 2026-01-14 | Buy | Hold | TD Cowen |
| 2025-10-23 | Buy | Hold | Deutsche Bank |
| 2025-09-25 | Buy | Neutral | Citigroup |
Interpretation
The current analyst sentiment suggests a complex assessment of CME's market position. The increase in Hold ratings reflects market uncertainty, while sporadic upgrades indicate selective optimism in certain areas of CME’s operations. The sentiment shifts and adaptations exhibited by analysts reflect an adaptive market approach, balancing caution with strategic insight.
Conclusion
In summary, CME Group Inc.'s analyst ratings present a mixed but strategic landscape of sentiment. While there is a noticeable shift towards Hold ratings, reflecting caution, analysts maintain a degree of optimism with strategic upgrades. Volatility in global markets necessitates this prudent approach, and CME's established footprint aids in navigating these complexities. Overall, while challenges persist, the resilient business model offers potential growth paths if market conditions stabilize.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years